Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
Glanzmann’s Research Foundation shared a post on LinkedIn:
“More than four years ago, we visited David Wilcox and his team at the Medical College of Wisconsin, where they have spent decades advancing a potential gene therapy cure for GlanzmannThrombasthenia.
Today, we are closer than ever to clinical trials, and we’ll soon be returning to the lab to see firsthand how much progress has been made.
The science is there. The expertise is there.
The biggest barrier to this research reaching patients is funding.
What makes the us so unique as a non-profit in the rare bleeding disorders space is that all donations directly support research to find a cure.
Every donation helps move this promising therapy one step closer to clinical trials.”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 10:18Neha Rastogi Panda: Empowering Young Women Through Health Awareness
-
Sep 28, 2026, 10:16S.0 MIKAYE – Hypertension in Pregnancy From Diagnosis to Management
-
Sep 28, 2026, 09:45Emma Groarke: The 3rd International VEXAS Conference in Milan
-
Sep 28, 2026, 09:36Iman Alshamsi: Thrombophilia Workup and PNH Screening When Testing Matters
-
Sep 28, 2026, 09:25Emadullah Raidullah: Thrombophilia Workup and PNH Screening When Testing Matters
-
Sep 28, 2026, 03:59Rahul Saha: JAMA The 49th Human Blood Group System
-
Sep 28, 2026, 01:51Ann Mullally: Expect to See Lots More Gene Therapy in Medicine in the Years Ahead
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is